Back to calendar
Damora Therapeutics, Inc. (DMRA) Earnings
DMRA reports earnings on Friday, October 30, 2026
earnings report
October 30, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.47
Actual EPS: $-0.39
EPS surprise: 5.79%
Company overview
Market Cap$1.8B
PriceUSD 29.00
EPS (TTM)-124.78
52-week high38.33
52-week low2.45
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees7